Overview

A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder.

Status:
Not yet recruiting
Trial end date:
2025-05-31
Target enrollment:
Participant gender:
Summary
A clinical trial to study the efficacy and safety of an investigational drug in people with major depressive episodes associated with with Bipolar I disorder (bipolar I depression) Participants in the study will either receive the drug being studied or a placebo. The study will be conducted in the United States, Europe and Japan. It will be have both male and female participants ages 18-65. Participation in the study will be approximately 10 weeks.
Phase:
Phase 3
Details
Lead Sponsor:
Sunovion